EMEA-001577-PIP03-17
Key facts
Invented name |
Descovy
|
Active substance |
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0139/2018
|
PIP number |
EMEA-001577-PIP03-17
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
Prevention of human immunodeficiency virus (HIV-1) infection
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Gilead Sciences International Ltd
E-mail: regulatory.pip@gilead.com |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
Compliance procedure number |
EMEA-C-001577-PIP03-17
|
Compliance opinion date |
20/09/2019
|
Compliance outcome |
positive
|